Global Deep Brain Stimulation Market – Industry Trends and Forecast to 2031

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Global Deep Brain Stimulation Market – Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • Количество таблиц: 60
  • Количество рисунков: 220

Global Deep Brain Stimulation Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Chart Image USD 649.67 Billion USD 1,247.75 Billion 2023 2031
Diagram Прогнозируемый период
2024 –2031
Diagram Размер рынка (базовый год)
USD 649.67 Billion
Diagram Размер рынка (прогнозируемый год)
USD 1,247.75 Billion
Diagram CAGR
%
Diagram Основные игроки рынка
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>Global Deep Brain Stimulation Market, By Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Others), End-Use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers) – Industry Trends and Forecast to 2031.

Deep Brain Stimulation Market

 

Deep Brain Stimulation Market Analysis and Size

As per the recent data the incidence of Parkinson's disease tends to increase with age, and it is estimated to be around 15-20 per 100,000 people per year in the general population. However, these figures can vary by region and demographic factors. Also, Essential tremor is one of the most common movement disorders. The incidence increases with age, and it is estimated to be around 5 per 1,000 people per year, but again, these rates can vary; Dystonia, a type of deep brain stimulator disease, is less common than Parkinson's disease and essential tremor. The incidence varies depending on the specific type of dystonia and its underlying causes. General estimates suggest a prevalence of about 30-732 cases per million individuals.

Data Bridge Market Research analyzes that the global deep brain stimulation market, which was USD 649.67 million in 2023, is likely to reach USD 1,247.75 million by 2031 and is expected to undergo a CAGR of 8.5% during the forecast period. “Single channel deep brain stimulator” dominates the product segment of the market due to the growing demand for better methods for treatment in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, and Pricing in USD

Segments Covered

Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Others), End-Use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa

Market Players Covered

Medtronic (Ireland), Boston Scientific Corporation (U.S.), Abbott (U.S.), Cyberonics, Inc. (U.S.), Nevro Corp. (U.S.), NeuroSigma, Inc. (U.S.), NeuroPace, Inc. (U.S.), Synapse Biomedical Inc. (U.S.), Neuronetics (U.S.), ReShape Lifesciences, Inc. (U.S.), Zynex Medical (U.S.), Functional Neuromodulation Ltd. (Canada), MicroTransponder Inc. (U.S.), Aleva Neurotherapeutics SA (Switzerland)

Market Opportunities

  • Expansion of indications
  • Personalized medicine and precision targeting

Market Definition

Deep brain stimulation (DBS) refers to a device used for the purpose of providing electrical incitement to some areas of the brain to control the movement. They are extensively utilized to treat diseases such as Parkinson’s disease, chronic pain, central pain syndrome, epilepsy and obsessive compulsive disorder among others.

Global  Deep Brain Stimulation Market Dynamics

Drivers

  • Increasing Prevalence of Neurological Disorders

DBS is primarily used to treat neurological disorders such as Parkinson's disease, essential tremor, and dystonia. As the prevalence of these disorders continues to rise globally, the demand for DBS as a therapeutic intervention also increases.

  • Advancements in Technology

Continuous advancements in deep brain stimulation technology, including improvements in electrode design, surgical techniques, and programming algorithms, contribute to the market growth. Enhanced technology often leads to better treatment outcomes and increased patient acceptance.

Opportunities

  • Expansion of Indications

There is an opportunity to explore and expand the applications of DBS beyond its current indications. Research and clinical trials are ongoing to assess the efficacy of DBS in treating conditions such as epilepsy, depression, obsessive-compulsive disorder (OCD), and other neuropsychiatric disorders.

  • Personalized Medicine and Precision Targeting

Advances in understanding the individualized nature of neurological disorders create opportunities for personalized medicine in DBS. Tailoring stimulation parameters and targeting specific brain regions based on the unique characteristics of each patient can optimize treatment outcomes.

Restraints/Challenges

  • High Cost of Treatment

The cost associated with DBS procedures, including the surgical implantation of electrodes and the required follow-up care, can be substantial. This high cost may limit access to DBS for some patients and pose challenges for widespread adoption.

  • Limited Understanding of Mechanisms of Action

The exact mechanisms of action of DBS are not fully understood, and the effects on neural circuits are complex. This lack of clarity may hinder the optimization of stimulation parameters and the development of more targeted and effective treatments.

This deep brain stimulation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the deep brain stimulation market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Global Deep Brain Stimulation Market Scope

The deep brain stimulation market is segmented on the basis of product, type, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator

Type

  • Subthalamic DBS
  • Globus Pallidus DBS
  • Thalamic DBS
  • Pedunculopontine Nucleus DBS

Application

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Obsessive-Compulsive Disorder (OCD)
  • Depression
  • Dystonia
  • Parkinson’s Disease
  • Others

End-Use

  • Hospitals
  • Neurology Clinics
  • Ambulatory Surgical Centers
  • Research Centers

Global Deep Brain Stimulation Market Regional Analysis/Insights

The deep brain stimulation market is analyzed and market size insights and trends are provided by country, product, type, application and end-use as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East & Africa.

North America is expected to dominate the market due to the increase in FDA approvals for deep brain stimulation devices in clinical applications, government funding and initiatives for raising awareness about movement disorders and rise in patients diagnosed with PD in the region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2024 to 2031 due to the prevalence of neurodegenerative disorders, demand for effective and long-term solutions, improvements in the clinical development framework and growth in awareness about neurological disease treatment options in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The deep brain stimulation market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the deep brain stimulation market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the deep brain stimulation market.

Competitive Landscape and Deep Brain Stimulation  Market Share Analysis

The deep brain stimulation market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the deep brain stimulation market.

Some of the major players operating in the deep brain stimulation market are:

  • Medtronic (Ireland)
  • Boston Scientific Corporation (U.S.)
  • Abbott (U.S.)
  • Cyberonics, Inc. (U.S.)
  • Nevro Corp. (U.S.)
  • NeuroSigma, Inc. (U.S.)
  • NeuroPace, Inc. (U.S.)
  • Synapse Biomedical Inc. (U.S.)
  • Neuronetics (U.S.)
  • ReShape Lifesciences, Inc. (U.S.)
  • Zynex Medical (U.S.)
  • Functional Neuromodulation Ltd. (Canada)
  • MicroTransponder Inc. (U.S.)
  • Aleva Neurotherapeutics SA (Switzerland)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

Рынок сегментирован на основе , By Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s Disease, Others), End-Use (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers) – Industry Trends and Forecast to 2031. .
Размер Global Deep Brain Stimulation Market в 2023 году оценивался в 649.67 USD Billion долларов США.
Ожидается, что Global Deep Brain Stimulation Market будет расти со среднегодовым темпом роста (CAGR) 8.5% в течение прогнозируемого периода 2024–2031.
Отчет по рынку охватывает данные из U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa.
Testimonial